| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Ammijin; Ammijin | CFN92711 | 495-30-7 | C20H24O9 = 408.4 | 5mg | QQ客服：2056216494 |
| 印度榅桲素; Marmesin | CFN92712 | 13710-70-8 | C14H14O4 = 246.3 | 20mg | QQ客服：2056216494 |
| O-Methylcedrelopsin; O-Methylcedrelopsin | CFN92731 | 72916-61-1 | C16H18O4 = 274.3 | 5mg | QQ客服：1457312923 |
| 5-Methoxysuberenone; 5-Methoxysuberenone | CFN92732 | 85011-58-1 | C15H14O5 = 274.3 | 5mg | QQ客服：215959384 |
| 飞龙掌血内酯; Toddaculine | CFN92733 | 4335-12-0 | C16H18O4 = 274.3 | 10mg | QQ客服：1413575084 |
| 飞龙掌血香豆醌; Toddacoumaquinone | CFN92734 | 142878-03-3 | C23H18O7 = 406.4 | 5mg | QQ客服：215959384 |
| Arteminin; Arteminin | CFN92736 | 466639-11-2 | C11H10O5 = 222.2 | 5mg | QQ客服：2159513211 |
| 水合氧化前胡素; Oxypeucedanin hydrate | CFN90557 | 2643-85-8 | C16H16O6 = 304.29 | 20mg | QQ客服：215959384 |
| 3',4'-二氢-3'-羟基-花椒内酯; 3',4'-dihydro-3'-hydroxy-Xanthyletin | CFN92775 | 5993-18-0 | C14H14O4 = 246.3 | 5mg | QQ客服：2159513211 |
| 顺式凯尔消旋内酯; cis-Khellactone | CFN92799 | 15645-11-1 | C14H14O5 = 262.3 | 5mg | QQ客服：215959384 |
| 前胡香豆精 G; Qianhucoumarin G | CFN92800 | 68692-61-5 | C14H14O5 = 262.3 | 5mg | QQ客服：1413575084 |
| 蜂蜜曲菌素; Mellein | CFN97913 | 480-33-1 | C10H10O3 = 178.2 | 5mg | QQ客服：2056216494 |
| 柠檬油素; Citropten | CFN97963 | 487-06-9 | C11H10O4 = 206.2 | 20mg | QQ客服：2159513211 |
| 3-(2,4-二羟基苯基)-7-羟基-5-甲氧基-2H-1-苯并吡喃-2-酮; 7,2',4'-Trihydroxy-5-methoxy-3-phenylcoumarin | CFN96001 | 1092952-62-9 | C16H12O6 = 300.3 | 5mg | QQ客服：3257982914 |
| 7-甲氧基香豆素; 7-Methoxycoumarin | CFN90566 | 531-59-9 | C10H8O3 = 176.2 | 20mg | QQ客服：2056216494 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)